Literature DB >> 10529044

A comparison of large volume spacer, breath-activated and dry powder inhalers in older people.

V Jones1, C Fernandez, P Diggory.   

Abstract

AIMS: To see if elderly people can use the breath-activated (Easi-breathe) and dry powder (Turbohaler) inhalers as effectively as the metered-dose inhaler and Volumatic system.
METHODS: 102 inhaler-naive patients (aged 75-101, mean 84 years), without cognitive impairment, were randomly allocated one of Easi-breathe, Turbohaler or metered-dose inhaler and Volumatic placebo inhalers. Standardized tuition was done on enrolment and at 6 h review. Inhaler technique was assessed immediately after enrolment tuition and at 6 and 24 h. Assessment was by scoring (0 = poor, 1 = moderate, 2 = perfect) five aspects of technique.
RESULTS: Mean total scores were significantly (P < 0.005) higher for Turbohaler and Easi-breathe than metered-dose inhaler and Volumatic on enrolment and 6 h and at 24 h (P < 0.045). Fewer patients achieved excellent scores of 9 or 10 when using metered-dose inhaler and Volumatic. The main difficulties were in assembling the metered-dose inhaler and Volumatic and detecting when the metered-dose inhaler and Volumatic or Easi-breathe was empty.
CONCLUSIONS: Breath-activated and dry powder inhalers were more likely to be used correctly than metered-dose inhalers with large volume spacers.

Entities:  

Mesh:

Year:  1999        PMID: 10529044     DOI: 10.1093/ageing/28.5.481

Source DB:  PubMed          Journal:  Age Ageing        ISSN: 0002-0729            Impact factor:   10.668


  11 in total

1.  Elderly people's technique in using dry powder inhalers. New inhaler devices are rarely used by older people in the community.

Authors:  L Dow; L Fowler; H Lamb
Journal:  BMJ       Date:  2001-07-07

Review 2.  Optimizing Treatment of Elderly COPD Patients: What Role for Inhaled Corticosteroids?

Authors:  Andrea P Rossi; Erika Zanardi; Mauro Zamboni; Andrea Rossi
Journal:  Drugs Aging       Date:  2015-09       Impact factor: 3.923

3.  From Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines to current clinical practice : an overview of the pharmacological therapy of stable chronic obstructive pulmonary disorder.

Authors:  Raffaele Antonelli Incalzi; Andrea Corsonello; Claudio Pedone; Giulio Masotti; Vincenzo Bellia; Vittorio Grassi; Franco Rengo
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

4.  Ability to learn inhaler technique in relation to cognitive scores and tests of praxis in old age.

Authors:  S C Allen; S Ragab
Journal:  Postgrad Med J       Date:  2002-01       Impact factor: 2.401

Review 5.  Routine Use of Budesonide/Formoterol Fixed Dose Combination in Elderly Asthmatic Patients: Practical Considerations.

Authors:  Nicola Scichilone; Fulvio Braido; Federico Lavorini; Mark L Levy; Omar S Usmani
Journal:  Drugs Aging       Date:  2017-05       Impact factor: 3.923

6.  Erratum to: Safety Considerations of Inhaled Corticosteroids in the Elderly.

Authors:  Salvatore Battaglia; Irene Cardillo; Federico Lavorini; Mario Spatafora; Nicola Scichilone
Journal:  Drugs Aging       Date:  2015-12       Impact factor: 3.923

Review 7.  Safety considerations of inhaled corticosteroids in the elderly.

Authors:  Salvatore Battaglia; Irene Cardillo; Federico Lavorini; Mario Spatafora; Nicola Scichilone
Journal:  Drugs Aging       Date:  2014-11       Impact factor: 3.923

Review 8.  Optimising Inhaled Pharmacotherapy for Elderly Patients with Chronic Obstructive Pulmonary Disease: The Importance of Delivery Devices.

Authors:  Federico Lavorini; Claudia Mannini; Elisa Chellini; Giovanni A Fontana
Journal:  Drugs Aging       Date:  2016-07       Impact factor: 3.923

Review 9.  Are inhaled systemic therapies a viable option for the treatment of the elderly patient?

Authors:  Stephen Allen
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

10.  Inhaler device technique can be improved in older adults through tailored education: findings from a randomised controlled trial.

Authors:  Melanie A Crane; Christine R Jenkins; Dianne P Goeman; Jo A Douglass
Journal:  NPJ Prim Care Respir Med       Date:  2014-09-04       Impact factor: 2.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.